(SYF) Synchrony Financial - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87165B1035
SYF: Credit Cards, Loans, Deposits, Financing
Synchrony Financial (NYSE:SYF) is a leading consumer financial services company specializing in credit products, banking solutions, and payment technologies. Established in 1932 and headquartered in Stamford, Connecticut, the company operates through subsidiaries to deliver tailored financial services across multiple industries. Its product portfolio includes private label credit cards, co-branded credit cards, installment loans, and deposit products such as CDs, IRAs, and savings accounts. Synchrony also offers debt cancellation products, healthcare financing through CareCredit and Walgreens, and industry-specific payment solutions for retail, auto, telecommunications, and outdoor sectors. The company partners with national and regional retailers, manufacturers, and healthcare providers to distribute its products, leveraging both digital and traditional channels. Synchrony serves a diverse range of industries, including digital, health, home, auto, and pet care.
Technically, SYF is currently trading at $47.23, below its 20-day SMA of $49.66 and 50-day SMA of $55.03. The stocks 200-day SMA stands at $56.20, indicating a downtrend in recent months. The Average True Range (ATR) of 2.88 suggests moderate volatility. On a fundamental basis, Synchronys market cap is $170.31 billion, with a P/E ratio of 5.12 and a forward P/E of 5.84. The price-to-book ratio is 1.11, and the price-to-sales ratio is 1.81. The companys return on equity (RoE) is 21.10%, reflecting strong profitability.
3-Month Forecast: - Technical Outlook: SYFs price is below its key moving averages, signaling bearish momentum. The 20-day SMA crossing below the 50-day SMA suggests continued weakness. Support levels may be tested near $44, with resistance at $52. - Fundamental Outlook: Synchronys low P/E ratio and high RoE indicate undervaluation and strong profitability. Expect moderate revenue growth driven by its healthcare and digital payment segments. The companys focus on partnerships and deposit growth could stabilize performance despite macroeconomic headwinds.Additional Sources for SYF Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SYF Stock Overview
Market Cap in USD | 18,609m |
Sector | Financial Services |
Industry | Credit Services |
GiC Sub-Industry | Consumer Finance |
IPO / Inception | 2014-07-31 |
SYF Stock Ratings
Growth Rating | 69.5 |
Fundamental | 64.8 |
Dividend Rating | 61.6 |
Rel. Strength | -1.61 |
Analysts | 4.13/5 |
Fair Price Momentum | 47.66 USD |
Fair Price DCF | 270.32 USD |
SYF Dividends
Dividend Yield 12m | 1.95% |
Yield on Cost 5y | 6.46% |
Annual Growth 5y | 2.59% |
Payout Consistency | 99.5% |
SYF Growth Ratios
Growth Correlation 3m | -92.4% |
Growth Correlation 12m | 66.6% |
Growth Correlation 5y | 53.9% |
CAGR 5y | 27.10% |
CAGR/Max DD 5y | 0.58 |
Sharpe Ratio 12m | 0.41 |
Alpha | 3.09 |
Beta | 1.538 |
Volatility | 43.52% |
Current Volume | 5001.8k |
Average Volume 20d | 5767.1k |
As of April 26, 2025, the stock is trading at USD 51.42 with a total of 5,001,802 shares traded.
Over the past week, the price has changed by +8.87%, over one month by -7.93%, over three months by -26.13% and over the past year by +17.38%.
Yes, based on ValueRay Fundamental Analyses, Synchrony Financial (NYSE:SYF) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 64.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SYF as of April 2025 is 47.66. This means that SYF is currently overvalued and has a potential downside of -7.31%.
Synchrony Financial has received a consensus analysts rating of 4.13. Therefor, it is recommend to buy SYF.
- Strong Buy: 10
- Buy: 6
- Hold: 7
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, SYF Synchrony Financial will be worth about 54.8 in April 2026. The stock is currently trading at 51.42. This means that the stock has a potential upside of +6.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 66.6 | 29.6% |
Analysts Target Price | 74.3 | 44.5% |
ValueRay Target Price | 54.8 | 6.6% |